...
首页> 外文期刊>Journal of Clinical Microbiology >Antimicrobial Susceptibility Testing and Profiling of Nocardia Species and Other Aerobic Actinomycetes from South Africa: Comparative Evaluation of Broth Microdilution versus the Etest
【24h】

Antimicrobial Susceptibility Testing and Profiling of Nocardia Species and Other Aerobic Actinomycetes from South Africa: Comparative Evaluation of Broth Microdilution versus the Etest

机译:南非诺卡氏菌和其他有氧放线菌的药敏试验和概况:肉汤微稀释与Etest的比较评价

获取原文
           

摘要

Nocardiosis is an underrecognized clinical entity in South Africa, for which interspecies epidemiological and clinical differences are poorly understood. The taxonomical state of flux and the lack of a simple antimicrobial susceptibility testing method are partly responsible. Definitive identification is molecularly based, which further complicates the study of this ubiquitous organism, as this methodology is beyond the scope of most routine diagnostic laboratories. The Etest methodology has been proposed as an alternative to the reference broth microdilution method, although there have been a limited number of comparative studies. We profiled 51 clinical isolates of aerobic actinomycetes, including 39 Nocardia species, using sequence-based (16S rRNA) identification. Broth microdilution and Etests were done concurrently on all isolates. The overall level of categorical and essential agreement for broth microdilution and Etest for the Nocardia isolates ranged from 67.5 to 100% and 46.2 to 81.6%, respectively. Very major errors were seen with amikacin, amoxicillin-clavulanate, ciprofloxacin, clarithromycin, and imipenem. For Nocardia species, uniform susceptibility to co-trimoxazole, amikacin, and linezolid was demonstrated, with a 48.8% susceptibility rate to imipenem. Nocardia farcinica (20.5%) and Nocardia cyriacigeorgica (15.4%) were the most commonly identified species among the 82% of isolates identified to species level using 16S rRNA sequences. Furthermore, drug susceptibility patterns demonstrated limited concordance with species identification. Our results suggest that, in a routine diagnostic setting, the Etest is not an acceptable alternative to the reference method of broth microdilution for antimicrobial susceptibility testing. Given the diversity and limited understanding of this group of organisms, further widespread evaluation of clinical isolates, from both clinical and diagnostic perspectives, is warranted.
机译:诺卡氏病是南非公认的临床实体,人们对其种间流行病学和临床差异了解甚少。助焊剂的分类状态和缺乏简单的抗菌药敏测试方法是部分原因。确定性鉴定是基于分子的,这使这种无处不在的生物的研究更加复杂,因为这种方法超出了大多数常规诊断实验室的范围。已提出了Etest方法作为参考肉汤微稀释法的替代方法,尽管比较研究的数量有限。我们使用基于序列的(16S rRNA)鉴定方法对51种有氧放线菌的临床分离株进行了分析,其中包括39种诺卡氏菌。同时对所有分离株进行肉汤微稀释和Etests试验。肉汤微稀释液和 Nocardia 分离株的Etest的分类和必要协议的总体水平分别为67.5%至100%和46.2%至81.6%。阿米卡星,阿莫西林-克拉维酸,环丙沙星,克拉霉素和亚胺培南出现了非常严重的错误。对于诺卡氏菌物种,对共曲莫唑,阿米卡星和利奈唑胺的敏感性一致,对亚胺培南的敏感性为48.8%。在使用16S rRNA序列鉴定到物种水平的82%分离株中,诺卡氏菌(20.5%)和 cynocigeorgicaica (15.4%)是最常见的物种。此外,药物敏感性模式与物种鉴定显示出有限的一致性。我们的结果表明,在常规诊断环境中,Etest不能代替肉汤微量稀释法作为抗药性试验参考方法。考虑到这一类生物的多样性和有限的了解,有必要从临床和诊断的角度对临床分离株进行进一步的广泛评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号